FDA Agreement on Mesoblast's Use of Singapore Manufacturing Facility for Clinical Trial Production of Proprietary Mesenchymal Precursor Cells

World News: . []

MELBOURNE Australia Feb 12 2013 GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) OTC ADRMBLTY today announced that United States Food and Drug Administration FDA is in agreement for Mesoblast to supply its proprietary Mesenchymal Precursor C ells (M...

More news and information about Mesoblast

Published By:

Globe Newswire: 01:28 GMT Wednesday 13th February 2013

Published: .

Search for other references to "agreement" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers